As of the latest Form 4 filed Jul 6, 2026.
What Integra LifeSciences Holdings insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Newest filing first — the 22 most recent filings for IART.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-06 | 2026-07-03 | Knight Lea Daniels EVP & Chief Financial Officer | FTax | −5.23K | $18.05 | $94.3K | No | Form 4 ↗ |
| 2026-07-06 | 2026-07-01 | Mosebrook Jeffrey SVP, Fin & Princ Acct Officer | FTax | −937.00 | $17.89 | $16.8K | No | Form 4 ↗ |
| 2026-05-11 | 2026-05-09 | BRADLEY KEITH Director | FTax | −882.00 | $13.92 | $12.3K | No | Form 4 ↗ |
| 2026-05-11 | 2026-05-07 | HILL BARBARA B Director | AAward | +17.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-11 | 2026-05-07 | HILL BARBARA B, Director | AAward | +6.64K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-11 | Veillon-Berteloot Chantal EVP & CHRO | FTax | −5.42K | $9.61 | $52.1K | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-11 | Knight Lea Daniels EVP & Chief Financial Officer | FTax | −8.09K | $9.61 | $77.7K | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-11 | Singh Harvinder EVP & PRESIDENT, INTERNATIONAL | FTax | −5.19K | $9.61 | $49.9K | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-11 | Singh Harvinder, EVP & PRESIDENT, INTERNATIONAL | MExercise | +18.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-11 | Singh Harvinder, EVP & PRESIDENT, INTERNATIONAL | FTax | −861.00 | $9.61 | $8.27K | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-11 | McBreen Michael J. EVP & President, CSS | FTax | −7.25K | $9.61 | $69.6K | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-11 | Mosebrook Jeffrey SVP, Fin & Princ Acct Officer | FTax | −806.00 | $9.61 | $7.75K | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-11 | DAVIS ROBERT T. JR. EVP & President, TT | FTax | −8.49K | $9.61 | $81.6K | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-10 | Singh Harvinder EVP & PRESIDENT, INTERNATIONAL | FTax | −601.00 | $9.55 | $5.74K | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-10 | Singh Harvinder, EVP & PRESIDENT, INTERNATIONAL | MExercise | +1.22K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-10 | McBreen Michael J. EVP & President, CSS | FTax | −2.35K | $9.55 | $22.5K | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-10 | Mosebrook Jeffrey SVP, Fin & Princ Acct Officer | FTax | −341.00 | $9.55 | $3.26K | No | Form 4 ↗ |
| 2026-03-12 | 2026-03-10 | DAVIS ROBERT T. JR. EVP & President, TT | FTax | −687.00 | $9.55 | $6.56K | No | Form 4 ↗ |
| 2026-01-07 | 2026-01-06 | Poul Mojdeh President & CEO | FTax | −542.00 | $13.13 | $7.12K | No | Form 4 ↗ |
| 2026-01-07 | 2026-01-06 | Poul Mojdeh, President & CEO | FTax | −848.00 | $13.13 | $11.1K | No | Form 4 ↗ |
| 2026-01-07 | 2026-01-06 | Poul Mojdeh, President & CEO | MExercise | +542.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-07 | 2026-01-06 | Poul Mojdeh, President & CEO | MExercise | +848.00 | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also IART’s full analysis or the market-wide insider trading feed. The tabs above jump to IART’s other SEC data.
Source: SEC Form 4 filings for IART, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.